Search the Newsreel

CENTRAL GARDEN & PET CO SEC Filing (Aug 13, 2026)

This article reports on a Form 144 SEC filing by CENTRAL GARDEN & PET CO (CENT) on August 13, 2026. The filing indicates a proposed sale of 3900 shares of Class A Common Stock, acquired through a gift in 2008, with an aggregate market …

Ascentage Pharma Corrects Timing for August 19, 2026 Interim Results Webcast

Wall Street Analysts Believe Central Garden (CENTA) Could Rally 28.12%: Here's is How to Trade

Central Garden (CENTA) closed the last trading session at $38.83, gaining 2.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target …

Is Central Garden & Pet (CENTA) Outperforming Other Consumer Discretionary Stocks This Year?

The Consumer Discretionary group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Is Central Garden (CENTA) one of those stocks right now? By taking a look at the stock's year-to-date performance in comparison to …

Ascentage Pharma to Participate in the Evercore 2nd Annual China Biotech Summit

Ascentage Pharma Group International will participate in the Evercore ISI 2nd Annual China Biotech Summit in Shanghai, Pudong from August 17-19, 2026. Management will engage in a fireside chat on August 18, 2026, and conduct one-on-one investor meetings. The company is a global biopharmaceutical …

Transcenta Sets August Board Meeting to Review Interim Results and Dividend

Central Garden & Pet (NASDAQ:CENTA) Insider Sells $192,500.00 in Stock

Central Garden & Pet (CENT) chair exercises 127,942-share option and withholds shares

William E. Brown, Chairman and 10% owner of Central Garden & Pet Co (CENT), exercised stock options for 127,942 Class A Common Stock shares at $31.176 per share. A significant portion (116,232 shares) was withheld to cover the exercise price and tax liability. Brown …

Central Garden & Pet Co (CENT) executive reports sale of 10,000 Class A shares

John D. Walker III, President, Garden Consumer Pro at Central Garden & Pet Co (CENT), reported selling a total of 10,000 Class A Common Stock shares in two open-market transactions. He sold 5,000 shares on August 11, 2026, at $38.50 per share and another …

Centaurus Metals (ASX:CTM): Jaguar Nickel Project Tests the Recovery Potential

Central Garden & Pet Co (CENTA) Earnings Forecast: Future EPS & Revenue Growth Estimates

Central Garden & Pet (CENT) investor files to sell 5,000 Class A shares

A holder of Central Garden & Pet Company Class A Common Stock has filed a Form 144 notice to sell 5,000 shares through Charles Schwab & Co., Inc. The proposed sale is valued at $192,500.00 and is related to prior equity compensation activity, including …

Central Garden & Pet (CENT) chair shifts voting control on family trust shares

Central Garden & Pet (CENT) chairman, William E. Brown, reported indirect dispositions of Class A Common Stock due to changes in family trust control. He and his spouse ceased being co-trustees for two irrevocable trusts, impacting a total of 20,117 shares by removing their …

Central Garden & Pet Company $CENTA Shares Bought by Quantinno Capital Management LP

Centaurus Metals (ASX:CTM) Positions Jaguar as a Major Brazilian Nickel Development

Central Garden & Pet (CENT) Signals More Acquisitions After Majority Interest Deal

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Central Garden & Pet (NasdaqGS:CENT) is pursuing further acquisitions after agreeing to acquire a majority interest in TRIXIE Heimtierbedarf GmbH & Co. KG. …

Ascentage Pharma Group International (SEHK:6855) Adds Global Dealmakers As Fair Value Debate Builds

Central Garden & Pet Company (CENT) Stock Forecasts

Argus has lowered its target price for Central Garden & Pet Company (CENT) to $46.00. The report, published on August 5, 2026, highlights the company's focus on nurturing happy and healthy homes. Investors can access the full premium research report for detailed insights.

Central Garden & Pet (CENT) Stock Looks Reasonable On Earnings But Stretched On Value

Central Garden & Pet (NASDAQ:CENTA) Cut to Hold at Wall Street Zen

Ascentage Pharma Group International (AAPG) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Ascentage Pharma Group International (AAPG), highlighting that 9 analysts currently recommend a "Buy" rating with a target price indicating a significant upside. The report includes current stock performance and a peer comparison, but notes that specific financial …

Central Garden & Pet (NASDAQ:CENTA) Stock Price Down 6.1% - Time to Sell?

Shares of Central Garden & Pet (NASDAQ:CENTA) dropped 6.1% to $38.14 on Friday, with trading volume significantly below average. Despite this, analyst sentiment remains generally positive with a "Moderate Buy" consensus and an average price target of $46.67. The company recently surpassed quarterly earnings …

Ascentage Pharma Group International (NASDAQ:AAPG) Shares Gap Up - Time to Buy?

Central Garden & Pet Company (NASDAQ:CENTA) Given Average Rating of "Moderate Buy" by Brokerages

Central Garden & Pet Company (NASDAQ:CENTA) has received a "Moderate Buy" consensus rating from six brokerages, with an average 12-month price target of $46.67. The stock recently traded up 5.3% to $40.60, near its 52-week high, following a positive earnings report where its EPS …

Central Garden & Pet Company (CENTA) Stock forecasts

Argus released a report on Central Garden & Pet Co (CENTA) on August 5, 2026. The report provides a summary of the company, highlighting its focus on home and garden products for over forty years. The current price of the stock is $38.19.

Central Garden & Pet Company A stock hits 52-week high at $40.17

Central Garden & Pet Company A (CENTA) stock has reached a new 52-week high of $40.17, reflecting an impressive 32% year-to-date return. InvestingPro tips highlight the stock's low P/E ratio relative to near-term earnings growth, signaling strong investor confidence and positive market sentiment for …

Central Garden & Pet (CENT) Stock Jumps On Margin Gains And Higher Outlook

Ascentage Pharma Group International - ADR (AAPG) News, Articles, Events & Latest Updates

This article compiles recent news and updates concerning Ascentage Pharma Group International - Unsponsored ADR (AAPG). Several reports from Zacks and MarketBeat highlight Wall Street analysts' predictions of significant upside potential for AAPG, ranging from 152.23% to 160.09%. Other news items cover fluctuations in …

Central Garden & Pet Beats on Q3 Earnings, Raises FY26 EPS Outlook

Central Garden & Pet Company CENT reported third-quarter fiscal 2026 results, wherein the top and bottom lines beat the Zacks Consensus Estimate. Earnings declined year over year, while sales decreased due to the exit of the lower-margin pet distribution business. However, organic sales increased, …

Canaccord raises Central Garden & Pet stock price target on results

Canaccord has increased its price target for Central Garden & Pet Co. (NASDAQ:CENT) shares to $60 from $53, while maintaining a Buy rating. This adjustment follows the company's Q3 results, which showed sales in line with expectations and adjusted EBITDA slightly above consensus, despite …

Nubz® Flavor Bursts Win “Flavored Dog Treat Product of the Year” in 2026 Pet Innovation Awards

Pet Innovation Awards This annual awards program recognizes companies, services, and products within the rapidly expanding Pet Care industry that exemplify excellence & innovation. LOS ANGELES, Aug. 06, 2026 (GLOBE NEWSWIRE) -- The 2026 Pet Innovation Awards today announced that Nubz® Flavor Bursts, an …

Nylabone Wins “Chew Toy Product of the Year” In 2026 Pet Innovation Awards

Pet Innovation Awards This annual awards program recognizes companies, services, and products within the rapidly expanding Pet Care Industry that exemplify excellence & innovation LOS ANGELES, Aug. 06, 2026 (GLOBE NEWSWIRE) -- The 2026 Pet Innovation Awards today announced that Nylabone, an iconic brand …

Central Garden & Pet (NASDAQ:CENT) Sets New 12-Month High on Strong Earnings